课题基金 / 基金详情

INTERACTION OF CD-2 WITH LFA-3 IN T CELL ACTIVATION

INTERACTION OF CD-2 WITH LFA-3 IN T CELL ACTIVATION
T 细胞激活过程中 CD-2 与 LFA-3 的相互作用
批准号:
3455306
负责人:
Barbara E Bierer
金额:
$10.38万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-07-01 至 1994-06-30

项目摘要

项目成果

Barbara E Bierer的其他基金

相似基金

相关文献

中文摘要
翻译
人T淋巴细胞CD2 (Tll)分子在早期表达
英文摘要
The human T lymphocyte CD2 (Tll) molecule is expressed early in thymic ontogeny and on most human T cells. Several lines of evidence suggest that CD2 is a receptor involved in T cell adhesion, activation, and differentiation. A ligand for CD2 has been found to be lymphocyte-function associated antigen-3 (LFA-3). The proposed project focuses on the functional role of CD2 during T cell activation and its interaction with its ligand, LFA-3. The goal of this project is to understand the regulatory role of the CD2 molecule in T cell activation and to delineate the structural requirements of CD2 for both LFA-3 binding and for signal transduction. Mutated CD2 molecules which lack LFA-3 binding sites and activation-related CD2 epitopes will be generated, expressed in an antigen-specific T cell hybridoma, and analyzed. Deletion mutants of the CD2 cytoplasmic domain will be generated and analy to help to define the structural requirements for signaling through CD2. The wild type and mutated CD2 molecules will be used to analyze the mechanisms of signal transduction. Soluble LFA-3 will be produced in an efficient expression system, and used to charac- terize LFA3 binding to CD2. Synthetic peptides based on the amino acid sequence of CD2 and, later, LFA-3 will be analy to define more precisely the binding site. This approach may ultimately lead to the design of small molecule agonists or inhibitors of the CD2/LFA- 3 interaction. There is accumulating evidence that the CD2/LFA-3 interaction can augment the antigen-specific response. LFA-3 ligand binding to CD2 may enhance or modulate T cell activation. The definition of the minimum requirements for the CD2/LFA-3 receptor-ligand interaction and for signaling may contribute to our understanding of the regulation and modulation of the immune response. Understanding this interaction may ultimately lead to novel immunotherapeutic approaches to enhance the T cell response to weak viral or tumor-specific antigens.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Global Cooperation to Promote Clinical Research in Children
  • 批准号:
    10571693
  • 项目类别:
  • 资助金额:
    $5.46万
  • 财政年份:
    2021
  • 负责人:
    Barbara E Bierer
  • 依托单位:
Global Cooperation to Promote Clinical Research in Children
  • 批准号:
    10283478
  • 项目类别:
  • 资助金额:
    $14.1万
  • 财政年份:
    2021
  • 负责人:
    Barbara E Bierer
  • 依托单位:
Global Cooperation to Promote Clinical Research in Children
  • 批准号:
    10331087
  • 项目类别:
  • 资助金额:
    $2.0万
  • 财政年份:
    2021
  • 负责人:
    Barbara E Bierer
  • 依托单位:
Innovative statistical methodologies to subgroup analysis in clinical trials
  • 批准号:
    10038875
  • 项目类别:
  • 资助金额:
    $5.0万
  • 财政年份:
    2020
  • 负责人:
    Barbara E Bierer
  • 依托单位:
海外基金